Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder

References

• NICE [webpage on the Internet]Acute Alcohol Withdrawal. National Institute for Health and Care Excellence2015 Available from: http://pathways.nice.org.uk/pathways/alcohol-use-disordersAccessed June 10, 2017
   Google Scholar
• StewartSSwainSNICERoyal College of Physicians, LondonAssessment and management of alcohol dependence and withdrawal in the acute hospital, Royal College of PhysiciansClin Med2012123266271
   Web of Science ®Google Scholar
• BakkerPRvan HartenPNvan OsJAntipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactionsMol Psychiatry200813554455618180754
   PubMed Web of Science ®Google Scholar
• BozinaNKuzmanMRMedvedVJovanovicNSerticJHotujacLAssociations between MDR1 gene polymorphisms and schizophrenia and therapeutic response to olanzapine in female schizophrenic patientsJ Psychiatr Res2008422899717113599
   PubMed Web of Science ®Google Scholar
• DayaluPChouKLAntipsychotic-induced extrapyramidal symptoms and their managementExpert Opin Pharmacother2008991451146218518777
   PubMed Web of Science ®Google Scholar
• GieglingIDragoADolžanVGlutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidolPharmacogenet Genomics201121420621620859245
   PubMed Web of Science ®Google Scholar
• GunesAScordoMGJaansonPSerotonin and dopamine receptor gene polymorphisms and risk of extrapyramidal side effects in perphenazine-treated schizophrenic patientsPsychopharmacology2007190447948417102980
   PubMed Web of Science ®Google Scholar
• GuzeyCScordoMGSpinaEAntipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphismsEur J Clin Pharmacol200763323324117225991
   PubMed Web of Science ®Google Scholar
• HoriHOhmoriOShinkaiTKojimaHNakamuraJAssociation between three functional polymorphisms of dopamine D2 receptor gene and tardive dyskinesia in schizophreniaAm J Med Genet2001105877477811803529
   PubMed Web of Science ®Google Scholar
• IraEZanoniMRuggeriMDazzanPTosatoSCOMT, neuropsychological function and brain structure in schizophrenia: a systematic review and neurobiological interpretationJ Psychiatry Neurosci201338636638023527885
   PubMed Web of Science ®Google Scholar
• JonssonEGNothenMMGrunhageFPolymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteersMol Psychiatry19994329029610395223
   PubMed Web of Science ®Google Scholar
• LachmanHMPapolosDFSaitoTYuYMSzumlanskiCLWeinshilboumRMHuman catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disordersPharmacogenetics1996632432508807664
   PubMedGoogle Scholar
• LafuenteABernardoMMasSDopamine transporter (DAT) genotype (VNTR) and phenotype in extrapyramidal symptoms induced by antipsychoticsSchizophr Res2007901–311512217150335
   PubMed Web of Science ®Google Scholar
• LaiICWangYCLinCCBaiYMLiaoDLYuSCNegative association between catechol-O-methyltransferase (COMT) gene Val158Met polymorphism and persistent tardive dyskinesia in schizophreniaJ Neural Transm200511281107111315583953
   PubMed Web of Science ®Google Scholar
• MännistöPTUlmanenILundströmKCharacteristics of catechol O-methyl-transferase (COMT) and properties of selective COMT inhibitorsProg Drug Res1992392913501475365
   PubMedGoogle Scholar
• MatsumotoCShinkaiTHoriHOhmoriONakamuraJPolymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophreniaPsychiatry Res20041271–21715261699
   PubMed Web of Science ®Google Scholar
• MiharaKSuzukiAKondoTNo relationship between TaqIA polymorphism of dopamine D2 receptor gene and extrapyramidal adverse effects of selective D2 antagonists, bromperidol and nemonapride in schizophrenia: a preliminary studyAm J Med Genet20009642242410898926
   PubMed Web of Science ®Google Scholar
• NevilleMJohnstoneEWaltonRIdentification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1Hum Mutat200423654054515146457
   PubMed Web of Science ®Google Scholar
• PohjalainenTRinneJONågrenKThe A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteersMol Psychiatry1998332562609672901
   PubMed Web of Science ®Google Scholar
• SegmanRHGoltserTHeresco-LevyUAssociation of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophreniaPharmacogenomics J20033527728314583797
   PubMed Web of Science ®Google Scholar
• SychevDAZastrozhinMSSmirnovVVGrishinaEASavchenkoLMBryunEAThe correlation between CYP2D6 isoenzyme activity and haloperidol efficacy and safety profile in patients with alcohol addiction during the exacerbation of the addictionPharmacogenomics Pers Med201698995
   Web of Science ®Google Scholar
• Russian Society of PsychiatristsThe Standard of Specialized Medical Care in the Dependence Syndrome Caused by the Use of Psychoactive SubstancesThe Ministry of Health of Russian Federation20169 Available from: http://psychiatr.ru/download/2685?view=1&name=302.pdfAccessed June 10, 2017
   Google Scholar
• ThompsonJThomasNSingletonAD2 dopamine receptor gene (DRD2) Taql A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allelePharmacogenetics1997764794849429233
   PubMedGoogle Scholar
• TsaiHTNorthKEWestSLPooleCThe DRD3 rs6280 polymorphism and prevalence of tardive dyskinesia: a meta-analysisAm J Med Genet B Neuropsychiatr Genet201015315766
   Google Scholar
• XuMXingQLiSPharmacogenetics effects of dopamine transporter gene polymorphisms on response to chlorpromazine and clozapine and extrapyramidal syndrome in schizophreniaProg Neuropsychopharmacol Biol Psychiatry20103461026103220580759
   PubMed Web of Science ®Google Scholar
• YoderKKHutchinsGDMorrisEDBrashearAWangCShekharADopamine transporter density in schizophrenic subjects with and without tardive dyskinesiaSchizophr Res2004712–337137515474908
   PubMed Web of Science ®Google Scholar
• ZaiCCDe LucaVHwangRWMeta-analysis of two dopamine D2 receptor gene polymorphisms with tardive dyskinesia in schizophrenia patientsMol Psychiatry200712979479517767146
   PubMed Web of Science ®Google Scholar
• ZastrozhinMSSmirnovVVSychevDASavchenkoLMBryunEAMatisOACYP3A4 activity and haloperidol effects in alcohol addictsInt J Risk Saf Med201527suppl 1S23S2426639694
   PubMedGoogle Scholar
• ZivkovićMMihaljević-PelesABozinaNSagudMNikolac-PerkovicMVuksan-CusaBThe association study of polymorphisms in DAT, DRD2 and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidolJ Clin Psychopharmacol201333559359923963056
   PubMed Web of Science ®Google Scholar